观察者间的变化和诊断性能在预测胰腺导管内皮质粘性新生体的恶性瘤与MRI

Seo-Youn Choi1, Ji Hye Min1, Jung Hoon Kim1

  • 1From the Departments of Radiology (S.Y.C.) and Biostatistics, Clinical Trial Center (J.E.M.), Soonchunhyang University College of Medicine, Bucheon Hospital, Bucheon, Republic of Korea; Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea (J.H.M., J.H.L.); Department of Radiology and Research Institute of Radiological Science, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea (J.H.K.); Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea (H.J.P.); Department of Radiology, Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea (Y.Y.K.); Department of Radiology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea (Y.E.H.); Department of Radiology, Soonchunhyang University College of Medicine, Seoul Hospital, Seoul, Republic of Korea (S.H.B.); and School of Health and Environmental Science, College of Health Science, Korea University, Seoul, Republic of Korea (Y.H.C.).

Radiology
|July 25, 2023
PubMed
概括

2017年胰腺导管内 papillary 粘膜瘤 (IPMN) 的指导方针显示,对高风险的污名的MRI诊断性能良好. 经验丰富的放射科医生达成更好的协议,但令人担忧的特征显示解释不那么一致.